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Understanding the sensory mechanisms innervating the bladder is paramount to developing efficacious treatments for chronic bladder
hypersensitivity conditions. The contribution of Mas-gene-related G protein-coupled receptors (Mrgpr) to bladder signaling is currently
unknown. Using male and female mice, we show with single-cell RT-PCR that subpopulations of DRG neurons innervating the mouse
bladder express MrgprA3 (14%) and MrgprC11 (38%), either individually or in combination, with high levels of coexpression with
Trpv1 (81%-89%). Calcium imaging studies demonstrated MrgprA3 and MrgprC11 agonists (chloroquine, BAM8-22, and neuropeptide
FF) activated subpopulations of bladder-innervating DRG neurons, showing functional evidence of coexpression between MrgprA3,
MrgprC11, and TRPV1. In ex vivo bladder-nerve preparations, chloroquine, BAM8-22, and neuropeptide FF all evoked mechanical
hypersensitivity in subpopulations (20%-41%) of bladder afferents. These effects were absent in recordings from Mrgpr-clusterD2/2
mice. In vitro whole-cell patch-clamp recordings showed that application of an MrgprA3/C11 agonist mixture induced neuronal hyper-
excitability in 44% of bladder-innervating DRG neurons. Finally, in vivo instillation of an MrgprA3/C11 agonist mixture into the blad-
der of WT mice induced a significant activation of dorsal horn neurons within the lumbosacral spinal cord, as quantified by pERK
immunoreactivity. This MrgprA3/C11 agonist-induced activation was particularly apparent within the superficial dorsal horn and the
sacral parasympathetic nuclei of WT, but not Mrgpr-clusterD2/2 mice. This study demonstrates, for the first time, functional expres-
sion of MrgprA3 and MrgprC11 in bladder afferents. Activation of these receptors triggers hypersensitivity to distension, a critically
valuable factor for therapeutic target development.
Key words: bladder; GPCR; itch; pain; sensory neurons; visceral afferents
Significance Statement
Determining how bladder afferents become sensitized is the first step in finding effective treatments for common urological disor-
ders such as overactive bladder and interstitial cystitis/bladder pain syndrome. Here we show that two of the key receptors,
MrgprA3 and MrgprC11, that mediate itch from the skin are also expressed on afferents innervating the bladder. Activation of these
receptors results in sensitization of bladder afferents, resulting in sensory signals being sent into the spinal cord that prematurely
indicate bladder fullness. Targeting bladder afferents expressing MrgprA3 or MrgprC11 and preventing their sensitization may pro-
vide a novel approach for treating overactive bladder and interstitial cystitis/bladder pain syndrome.
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Introduction
Patients suffering from common urological disorders, such as
overactive bladder and interstitial cystitis/bladder pain syn-
drome, experience chronic urinary urgency, frequency, and dis-
comfort or pain (Abrams et al., 2002; Homma et al., 2020).
Hypersensitivity of the peripheral afferents innervating the blad-
der are considered a key component in the underlying sympto-
mology of these conditions (de Groat et al., 2015; Grundy et al.,
2018a; de Groat and Yoshimura, 2009b). Numerous nociceptive
ion channels and receptors, including TRPV1 and P2X3, have
been identified as contributing to bladder afferent hypersensitiv-
ity, and have been subsequently explored to develop novel treat-
ments for bladder disorders (Daly et al., 2007; de Groat and
Yoshimura, 2009b; DeBerry et al., 2014; Yoshimura et al., 2014;
Grundy et al., 2018c; Spencer et al., 2018; Andersson, 2019).
However, other mechanisms are also likely involved. In this
regard, cues can be taken from sensations that originate from the
skin, whereby itch and pain are commonly experienced protec-
tive sensations that occur in response to irritant or noxious stim-
uli (Steinhoff et al., 2018). Both of these processes require
activation and sensitization of sensory afferents that project from
the skin into the dorsal horn of the spinal cord where they pro-
vide input to the CNS (T. Liu and Ji, 2013; LaMotte et al., 2014;
Schmelz, 2015; J. S. Lee et al., 2016). Interestingly, itch can be
mediated by histamine release from immune cells, which acti-
vate histamine receptors on sensory afferents (Shim and Oh,
2008), while several histamine-independent itch mechanisms
have also been described. These include those dependent on
Mas-related G-protein coupled receptors (Mrgprs) (Tominaga
and Takamori, 2014; Zhu et al., 2017), a large subfamily of
GPCRs predominantly expressed in the DRG (Dong et al.,
2001; Lembo et al., 2002). In particular, MrgprA3 has been
identified as the receptor responsible for itch associated with
the antimalarial drug chloroquine (Q. Liu et al., 2009), while
MrgprC11 activation via the endogenous peptide agonist bo-
vine adrenal medulla 8-22 (BAM8-22) or mast cell mediator
neuropeptide FF (NPFF), a dual MrgprC11 and A4 agonist
(Q. Liu et al., 2009) also initiate pruritus and scratching (M.
G. Lee et al., 2008; Sikand et al., 2011).
Traditionally these mechanisms have been considered unique to
the skin; however, pruritogenic-like mechanisms are being increas-
ingly identified in the viscera. The same histamine receptors that
mediate pruritus have been explored in a number of visceral organs,
including the gastrointestinal tract and bladder, where histamine
has been found to activate and induce hypersensitivity of visceral
afferents (Kreis et al., 1998; Wouters et al., 2016; Grundy et al.,
2020). More recently, MrgprC11 and MrgprA3 have been localized
in subpopulations of colon-innervating afferents (Castro et al., 2019;
Van Remoortel et al., 2019), as well as vagal afferents innervating
the lungs (Han et al., 2018). Activation of MrgprA3 and MrgprC11
expressed on colonic afferents results in colonic hypersensitivity,
enhanced abdominal pain, and altered animal behaviors (Castro et
al., 2019; Van Remoortel et al., 2019), effects that were significantly
increased in an animal model of chronic visceral hypersensitivity
(Castro et al., 2019). Given the relative similarities in the extrinsic
sensory afferent innervation of the colon and bladder, including the
ability to encode a variety of nociceptive and non-nociceptive stim-
uli (Brierley et al., 2004; Zagorodnyuk et al., 2006; Xu and Gebhart,
2008; Grundy et al., 2019a), we sought to explore the expression of
key Mrgprs in the bladder and their role in mediating neuronal
excitability and bladder sensory signaling.
Here, we show that MrgprC11, MrgprA3, and to a much
smaller extent MrgprD are expressed in subpopulations of
bladder-innervating DRG neurons. Agonists of MrgprC11 and
MrgprA3 cause pronounced afferent hypersensitivity to bladder
distension ex vivo, activate and evoke hyperexcitability of blad-
der-innervating DRG neurons in vitro, and enhance activation of
neurons within the dorsal horn of the spinal cord in vivo.
Materials and Methods
Ethics and animals
In this study, a total of 12- to 18-week-old male (N=39) and female
(N= 21) C57BL/6J mice from an in-house breeding colony at the South
Australian Health and Medical Research Institute (SAHMRI) were used.
Mice were acquired from an in-house C57BL/6J breeding program (JAX
strain #000664; originally purchased from The Jackson Laboratory,
breeding barn MP14) and then bred within the specific and opportunis-
tic pathogen-free animal care facility at SAHMRI. A genetically modified
mouse strain lacking a cluster of MRGPR genes (Mrgpr-clusterD/),
including MrgprA3 and MrgprC11, was utilized for some experiments
(Q. Liu et al., 2009). The Mrgpr-clusterD/ mice were a generous gift
from Prof. Xinzhong Dong (Howard Hughes Medical Institute, Johns
Hopkins University) and then bred in-house at SAHMRI as per the
C57BL/6J mice. All experiments were approved by and performed in ac-
cordance with the approval of the SAHMRI Animal Ethics Committee
(SAM195 and SAM190). Mice were group housed (up to 5 mice per
cage) within individual ventilated cages filled with chip coarse dust-free
aspen bedding (catalog #ASPJMAEBCA; PuraBed), with free access to
LabDiet JL Rat and Mouse/Auto6F chow (catalog #5K52) and autoclaved
reverse osmosis water. Cages were stored within a temperature-con-
trolled environment of 22°C and a 12 h light/12 h dark cycle on individ-
ual ventilated cage racks. Experiment sample sizes are detailed in the
corresponding figure legends.
Ex vivo bladder afferent nerve recordings
Nerve recording was performed using a previously described ex vivo
model in male mice (N=5/cohort) (Grundy et al., 2018b,c, 2019b, 2020;
Konthapakdee et al., 2019). Mice were humanely killed via CO2 inhala-
tion, and the entire lower abdomen was removed and submerged in a
modified organ bath under continual perfusion with gassed (95% O2
and 5% CO2) Krebs-bicarbonate solution (composition in mM as follows:
118.4 NaCl, 24.9 NaHCO3, 1.9 CaCl2, 1.2 MgSO4, 4.7 KCl, 1.2 KH2PO4,
11.7 glucose) at 35°C. The bladder, urethra, and ureters were exposed by
removing excess tissue. Ureters were tied with 4-0 perma-hand silk
(Ethicon, #LA53G). The bladder was catheterized (PE 50 tubing)
through the urethra and connected to a syringe pump (NE-1000) to
allow a controlled fill rate of 30ml/min with saline (NaCl, 0.9%). A sec-
ond catheter was inserted through the dome of the bladder, secured with
silk, and connected to a pressure transducer (NL108T2; Digitimer) to
enable intravesical pressure recording during graded distension. Pelvic
nerves, isolated from all other nerve fibers between the pelvic ganglia
and the spinal cord, were dissected into fine multiunit branches; and a
single branch was placed within a sealed glass pipette containing a
microelectrode (WPI) attached to a Neurolog headstage (NL100AK;
Digitimer). Nerve activity was amplified (NL104), filtered (NL 125/126,
bandpass 50-5000Hz, Neurolog; Digitimer), and digitized (CED 1401;
Cambridge Electronic Design) to a PC for offline analysis using Spike2
software (Cambridge Electronic Design). The number of action poten-
tials crossing a preset threshold at twice the background electrical noise
was determined per second to quantify the afferent response. Single-unit
analysis was performed offline by matching individual spike waveforms
through linear interpolation using Spike2 version 5.18 software. A single
unit was deemed to be responsive to an agonist if a .20% increase in
neuronal excitability (impulses/s across all distension pressures 0-30
mmHg area under the curve) was detected.
Afferent recording experimental protocols. At the start of each affer-
ent recording experiment, control bladder distensions were performed
with intravesical infusion of saline (NaCl, 0.9%) at a rate of 30ml/min to
a maximum pressure of 30mmHg at 10min intervals to assess the viabil-
ity of the preparation and reproducibility of the intravesical pressure and
neuronal responses to distension. The volume in the bladder was
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extrapolated from the known fill rate (30ml/min) and the time taken (s)
to reach maximum pressure (30mmHg). Compliance was determined
by plotting intravesical pressure against the calculated volume. After a
stable baseline was maintained, the saline in the infusion pump was
replaced by BAM8-22 (20 mM; Tocris Bioscience; #1763), chloroquine
(100 mM; Sigma Millipore, #PHR1258-1G), NPFF (50 mM; Tocris
Bioscience; #3137), or an “itch cocktail” containing all three agonists
combined (BAM8-22: 20 mM, chloroquine: 100 mM, and NPFF: 50 mM).
All experimental compounds were dissolved in dH2O to form stock sol-
utions, which were frozen at 80°C and defrosted immediately before
being used for each experiment. The single nerve bundle isolated and
inserted into the glass electrode during the dissection process was con-
tained within the recording electrode for the entire experiment, allowing
multiunit afferent nerve recordings to be performed and comparisons
between afferent firing rates to be compared in the same nerve fibers
during intrabladder incubation with saline and Mrgpr agonists.
Retrograde tracing from the bladder
A small, aseptic, abdominal incision was made in anesthetized (2%-4%
isoflurane in oxygen) male (N=9) and female (N= 3) mice. A 5ml
Hamilton syringe attached to a 30-gauge needle was used to inject chol-
era toxin subunit B conjugated to AlexaFluor-488 (CTB-488, 0.5%
diluted in 0.1 M PBS, pH 7.4; Thermo Fisher Scientific) at three sites into
the bladder wall (3ml/injection) (Grundy et al., 2018a,b, 2020). To pre-
vent injection of CTB into the bladder lumen, the needle was inserted
subserosally, parallel with the bladder muscle. The abdominal incision
was then sutured closed and analgesic (buprenorphine [Temvet];
0.1mg/kg; Troy Laboratories, APVMA #67612) and antibiotic (amoxi-
cillin; 50mg/kg; Amoxil, AUSTR11137) administered subcutaneously as
mice regained consciousness. Following laparotomy, mice were individ-
ually housed and allowed to recover. After 4 d, mice were humanely
killed by CO2 asphyxiation and the lumbosacral (LS; L5-S1) DRG
removed for subsequent isolation and culture of the neurons to visualize
CTB-labeled bladder innervating neurons among the DRG neurons.
mRNA expression analysis in DRG, isolated urothelial cells, and bladder
mucosal and detrusor layers
Tissue collection and urothelial cell isolation. Sixteen- to 18-week-old
male (N=6) and female (N= 8) mice were humanely killed via CO2 in-
halation and the bladder and lumbosacral (L5-S1) DRG removed. DRGs
were frozen in dry ice in pairs by spinal level (L5, L6, S1) and stored at
80°C for RNA extraction and qRT-PCR. The bladder was opened,
stretched out and pinned flat, urothelial side up. For tissue qRT-PCR,
the mucosal and detrusor layers were gently peeled apart, frozen in dry
ice, and stored at 80°C for RNA extraction and qRT-PCR. For urothe-
lial cell qRT-PCR, urothelial cells were isolated as performed previously
(Grundy et al., 2018c, 2020; Spencer et al., 2018). Following a rinse in
sterile PBS, the bladder was incubated for 3 h at room temperature in
DMEM containing 2.5mg/ml dispase (Invitrogen, Thermo Fisher
Scientific, #17105041), 10% FCS, and 1 mM/ml HEPES (Sigma Millipore,
#H3375, pH 7.0). A blunt scalpel was used to collect cells by gentle scrap-
ing of the urothelium. Cells were dissociated in 0.025% trypsin EDTA
(Invitrogen, Thermo Fisher Scientific, #25200072) at 37°C in 5% CO2
for 10min with gentle intermittent trituration. The cell suspension was
then added to DMEM containing 10% FCS to deactivate the trypsin
before centrifugation (15min, 1500 rpm, 4°C). Following aspiration of
supernatant, cells were resuspended in keratinocyte serum-free media
(Invitrogen, #17005042), and cell count and viability were determined
using the Countess Automated Cell Counter (Invitrogen, Thermo Fisher
Scientific). Cells were pelleted, frozen in dry ice, and stored at80°C for
RNA extraction and qRT-PCR.
RNA extraction. RNA was extracted using the PureLink RNA Micro
kit (Invitrogen, #12183-016; DRG pairs and isolated urothelial cells) or
the PureLink RNA Mini kit (Invitrogen, #12183018A; bladder mucosa
and detrusor) with DNase treatment (Invitrogen, #12185-010) according
to the manufacturer’s instructions. A NanoDrop Lite spectrophotometer
(Thermo Fisher Scientific) was used to determine RNA purity and quan-
tity. Using SuperScript VILO Master Mix (Invitrogen, #11755250), RNA
was reverse-transcribed to cDNA as per the manufacturer’s instructions.
cDNA was then stored at20°C for qRT-PCR.
qRT-PCR. qRT-PCR was performed using TaqMan Gene Expression
Master Mix (Applied Biosystems, #4369016) with commercially available
hydrolysis probes (TaqMan; Invitrogen; for details, see Table 1) and
RNase-free water (Ambion, #AM9916). For each reaction, 10ml of qPCR
MasterMix, 1ml of TaqMan primer assay, 4ml of water, and 5ml of
cDNA (1:2 dilution in RNA-free H2O) from each sample were tested in
duplicate for each target. Endogenous controls Actb (b -actin; DRG
pairs) and Gapdh and Hprt (glyceraldehyde 3-phosphate dehydrogenase
and hypoxanthine phosphoribosyltransferase 1; mucosal and detrusor
tissue layers and isolated urothelial cells) were used as endogenous con-
trols. Assays were run for 45 cycles on a 7500 Fast Real-Time PCR
System (Applied Biosystems) machine, using 7500 Fast software, version
2.0.6. mRNA quantities are expressed as 2-DCt relative to reference gene
Actb (DRG pairs) or Gapdh x Hprt (geometric mean; mucosa, detrusor,
and urothelial cells) (Grundy et al., 2018b,d; Castro et al., 2019).
Cell culture of bladder-innervating DRG neurons
Four days following retrograde tracing, mice were humanely killed via CO2
inhalation and lumbosacral (LS; L5-S1) DRGs were removed. DRGs were
digested in HBSS (pH 7.4, Invitrogen, #14170161) containing 2.5mg/ml
collagenase II (Invitrogen, Thermo Fisher Scientific, #17101015) and
4.5mg/ml dispase (Invitrogen, Thermo Fisher Scientific, #17105041) at
37°C for 30min. Following aspiration of the collagenase-dispase solution,
DRGs were incubated in HBSS containing collagenase (4.5mg/ml) only for
10min at 37°C. After subsequent washes in HBSS, trituration through fire-
polished Pasteur pipettes of descending diameter in 600ml complete
DMEM (Invitrogen, Thermo Fisher Scientific, #11995065), 10% FCS
(Invitrogen, Thermo Fisher Scientific), 2 mM L-glutamine (Invitrogen,
Thermo Fisher Scientific, #25030081), 100 mM MEM nonessential amino
acids (Invitrogen, Thermo Fisher Scientific, #11140076), 100mg/ml penicil-
lin/streptomycin (Invitrogen, Thermo Fisher Scientific, #15070063), and
96mg/L nerve growth factor-7S (Sigma Millipore, N0513-0.1MG) mechani-
cally disrupted DRGs and dissociated cells, which were then centrifuged for
1min at 50  g (Osteen et al., 2016; Inserra et al., 2017; Grundy et al.,
2018a,b). Supernatant was gently aspirated, and neurons resuspended in
360ml complete DMEM and spot-plated (30ml) onto laminin (20mg/ml;
Sigma Millipore, #L2020) and poly-D-lysine (800mg/ml; Thermo Fisher
Scientific) coated 13 mm coverslips. Coverslips were incubated for 2-3 h at
37°C in 5% CO2 to allow adherence of neurons before flooding with 1.7 ml
complete DMEM. Cultured neurons were then maintained in an incubator
at 37°C in 5% CO2 for 18-48 h for calcium imaging, patch-clamp record-
ings, or 4 h for cell picking for single-cell RT-PCR (Grundy et al., 2018b;
Castro et al., 2019).
Single-cell RT-PCR of individual bladder-innervating DRG neurons
Under continuous perfusion of sterile and RNA-/DNase-free PBS, single
retrogradely traced bladder DRG neurons were identified using a fluo-
rescence microscope and collected into the end of a fine glass capillary
using a micromanipulator (Grundy et al., 2018b). The glass capillary
containing the cell was then broken into a sterile Eppendorf tube con-
taining 10ml of lysis buffer with DNase (TaqMan Gene Expression Cells-
to-CT Kit; Invitrogen, #4399002). A bath control was also taken for each
coverslip of cells and analyzed concurrently with cells. After lysis and
Table 1. Primers used for qRT-PCR and RT-PCR receptor expression assays
Gene alias Gene target Assay ID
b -actin (reference gene) Actb Mm00607939_s1
HPRT (reference gene) Hprt Mm00446968_m1
Gapdh (reference gene) Gapdh Mm99999915_g1
Tubulin-3 (neuronal marker) Tubb3 Mm00727586_s1
Mas-related G-protein receptor A3 MrgprA3 Mm02620679_s1
Mas-related G-protein receptor C11 MrgprX1 Mm02525847_g1
Mas-related G-protein receptor D MrgprD Mm01701850_s1
Transient receptor potential vanilloid 1 Trpv1 Mm01246300_m1
Transient receptor potential ankyrin 1 Trpa1 Mm01227437_m1
Transient receptor potential vanilloid 4 Trpv4 Mm00499025_m1
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DNase treatment, samples were immediately frozen on dry ice and
stored at 80°C until cDNA synthesis was performed. RNA was
reverse-transcribed to cDNA using SuperScript IV VILO Master Mix
with ezDNase Enzyme (Invitrogen, #11766500) as per the manufac-
turer’s instructions. cDNA was then stored at 20°C for real-time
PCR. Tubulin-3 expression was used as a neuronal marker and positive
control. Expression of each target gene within a single cell was deter-
mined by looking at the log (DRn) curve against cycle number. Only
amplification curves that exhibited an exponential phase that rose
steadily and eventually plateaued within 50 cycles were counted.
Calcium imaging of cultured DRG neurons
Cultured DRG neurons (18-48 h) were loaded with 2.5 mM fura-2-ace-
toxymethyl ester (fura-2 AM; Invitrogen, Thermo Fisher Scientific,
#F1221) in 0.01% pluronic F-127 (Invitrogen, Thermo Fisher Scientific,
#P3000MP) at 37°C for 30min followed by a 10min wash with HEPES
buffer (10 mM HEPES sodium salt, Sigma Millipore, #H7006-100G), 140
mM NaCl (Chem Supply, #SA046-3KG), 4 mM KCl (Chem Supply,
#PA054-500G), 5 mM D-glucose anhydrous (Chem Supply, #GA018-
500G), 2 mM CaCl2 (Scharlau, #CA01951000), and 2 mM MgCl2 (Sigma
Millipore, #M8266-100G), pH 7.40, before imaging at room temperature
(23°C) (Bellono et al., 2017; Grundy et al., 2018b, 2020). Emissions for
fura-2 AM were measured at 510 nm, following excitation at 340 and
380nm, using a Nikon TE300 Eclipse microscope equipped with a Sutter
DG-4/OF wavelength switcher, an Omega XF04 filter set for fura-2 AM,
a Photonic Science ISIS-3 intensified CCD camera, and Universal
Interface Card MetaFluor software. Retrogradely traced bladder DRG
neurons were identified by the presence of the CTB-488, visible with ex-
citation at 480 nm. Excitation at 480 nm was used only as an initial blad-
der neuron identifier; to prevent unnecessary photobleaching, images
were not obtained at 480 nm throughout the experiment. Fluorescence
images were obtained every 2 s using a 20 objective. Data were
recorded and further analyzed using MetaFluor software.
After an initial baseline reading to ensure cell fluorescence was stable,
indicating healthy cells, DRG neurons were stimulated with chloroquine
(1 mM; Sigma Millipore, #PHR1258-1G), BAM8-22 (2 mM; Tocris
Bioscience, #1763), and NPFF (5 mM; Tocris Bioscience, #3137) with
changes in intracellular calcium (Ca21i) monitored in real time. The
TRPV1 receptor agonist capsaicin (3 mM; Sigma Millipore, M2028) was
applied at the end of experiments. Ca21i is expressed as the ratio
between the fluorescence signals at 340 and 380 nM (fura-2 AM, 340/
380).
Patch-clamp electrophysiology of bladder-innervating DRG neurons
Current-clamp recordings. Whole-cell patch-clamp recordings in
current-clamp mode were made from retrogradely traced fluorescently
labeled lumbosacral (L5-S1) bladder-innervating DRG neurons using
borosilicate glass pipettes (WPI) fire-polished to 3-7 MV and back-filled
with an intracellular solution consisting of the following (in mM): 135
KCl, 2 MgCl2, 2 MgATP, 5 EGTANa, 10 HEPES-Na, adjusted to pH 7.3,
275 mOsm. Rheobase (amount of current required to fire an action
potential) was determined in normal extracellular bath solution (in mM
as follows: 140 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose,
adjusted to pH 7.4, 285 mOsm) by application of a series of depolarizing
pulses from a holding potential of 65mV (10 or 25pA increments
[480ms]) followed by hold at 65mV (100ms). Cells were continually
perfused with bath solution by a gravity-driven multibarrel perfusion
system positioned within 1 mm of the neuron under investigation
(Osteen et al., 2016; Grundy et al., 2018b,d). After baseline recordings in
external bath solution, an Mrgpr agonist itch cocktail (MrgprA3 agonist;
chloroquine 10 mM; Sigma Millipore, #PHR1258-1G; MrgprC11 agonist;
BAM8-22: 2 mM, Tocris Bioscience, #1763; MrgprC11/A4 agonist; NPFF
5 mM; Tocris Bioscience, #3137) was applied for a 2min incubation pe-
riod and a second recording was made.
In vivo spinal dorsal horn activation
In vivo bladder infusion. In vivo bladder infusion in anesthetized
mice was performed as previously described (Grundy et al., 2018b,
2020). Twelve-week-old female mice (N=5/cohort) were anesthetized
(isoflurane 2%-4% in oxygen), and a catheter (AS point style, 51 mm,
metal hub, 21-gauge needle [Hamilton, 7751-12]) was inserted into the
bladder via the urethra. Correct catheter placement was determined by
inserting gently until meeting resistance (bladder dome) and receding
slightly (2-3 mm) to avoid damaging the bladder wall. Urine was
removed using a suction syringe. Subsequently, a new catheter (AS point
style, 51 mm, metal hub, 21-gauge needle) was inserted, primed with ei-
ther vehicle (saline) or an Mrgpr agonist mixture (BAM8-22: 20 mM;
NPFF: 50mM; and chloroquine: 100 mM), and 100ml of solution was then
gently infused, without fully distending the bladder, and allowed to incu-
bate for 5min. Immediately following removal of the compound, mice
were administered an anesthetic overdose (intraperitoneal injection of
pentobarbitone, 1.1mg/g body weight; Lethabarb, Virbac Australia) fol-
lowed by 4% buffered PFA transcardial perfuse fixation.
Transcardial perfuse fixation and tissue dissection. After anesthetic
overdose, the thoracic cavity was opened and 0.5 ml heparinized saline
(50 IU in 5 ml; Pfizer) was injected into the left ventricle. A 22-gauge
needle attached to tubing and a peristaltic perfusion pump were then
inserted into the injection site. The right atrium was cut open, allowing
for perfusate drainage. Warm PB (0.1 M; 21.7 mM NaH2PO4 [Chem
Supply, #SA061-500G], 81 mM Na2HPO4 [VWR Chemicals, #102494C],
pH 7.2) was perfused, followed by ice-cold 4% PFA (Sigma Millipore,
#158127) in 0.1 M PB. Following complete PFA perfusion, the lumbosac-
ral spinal cord (determined by the level of DRG root insertion points;
the lowest rib was used as an anatomic marker of DRG level T13) was
removed and postfixed in 4% PFA in 0.1 M PB at 4°C for 18-20 h. After
postfixation, spinal cord segments were cryoprotected in 30% sucrose/
PB (Sigma Millipore, #S9378) for 48 h at 4°C, followed by a 48 h incuba-
tion at 4°C in 50% optimal cutting temperature (VWR, #C361603E)/
30% sucrose/PB solution before freezing in 100% optimal cutting
temperature using liquid nitrogen-cooled 2-methylbutane (Sigma
Millipore, #M32631). Frozen spinal cord segments were cryosec-
tioned (10 mm thick) and placed onto gelatin-coated slides for im-
munostaining. Sections were performed serially and distributed
over 6 slides, which were used for immunohistochemical localiza-
tion of phosphorylated-MAP-kinase ERK 1/2 (pERK) (Grundy et
al., 2018b, 2019b, 2020; Harrington et al., 2019). The number of
pERK-immunoreactive (pERK-IR) neurons were counted in L6-S2
spinal cord sections, with spinal segments determined ex vivo by the
shape of the dorsal horn (Lein et al., 2007).
Immunohistochemistry of pERK within the spinal cord. The dorsal
horn neurons activated by bladder infusion were identified by labeling
for neuronal activation marker, pERK, using the DAKO Omnis autos-
tainer (Agilent Technologies Australia), with DAB/HRP secondary anti-
body staining. Sections were processed via the University of Adelaide
Health and Medical Sciences Histology Services. pERK activation was
determined rather than c-Fos because of the rapidity of ERK phospho-
rylation (minutes compared with hours) (Gao and Ji, 2009). Given the
short-duration nature of the specific peripheral stimuli applied, the rapid
onset of pERK provides a more appropriate correlate. Further, quantifi-
cation of pERK activation is increasingly being utilized to identify spinal
activation to a range of peripheral stimuli (Jiang et al., 2015; Castro et al.,
2017; Grundy et al., 2018a,b, 2020). After air drying for 1 h, sections
were postfixed in formalin with a brief rinse in distilled water (dH2O)
before target retrieval at 97°C for 30min with EnVision FLEX TRS Low
pH target retrieval solution (citrate buffer, pH 6.1; K8005, Agilent
DAKO), followed by a wash step with wash buffer (GC807, DAKO
Omnis, Agilent). A 10 min protein block step with Serum-Free Protein
Block (X0909, Agilent DAKO) to prevent nonspecific binding was fol-
lowed by a 1 h incubation in primary antibody (pERK; 1:800) in
Antibody Diluent (S0809, Agilent DAKO). Following removal of excess
primary antibody with wash buffer, a 3 min incubation in Envision
FLEX Peroxidase-blocking Reagent (GV823, Agilent DAKO) was per-
formed. Slides were then washed twice with wash buffer before a 20 min
incubation with Envision FLEX HRP Polymer (GV823, Agilent DAKO)
for HRP binding. A further 2 wash steps were performed, followed by a
DI rinse and a third wash step, before a 10 min incubation in EnVision
FLEX Substrate Working Solution (DAB) for staining. Slides underwent
alternate cycles of wash buffer, DI rinse, and wash buffer before a 3 min
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incubation with hematoxylin ready-to-use solution
(K8018, Agilent DAKO) and a further DI rinse and
wash step. Slides were removed from the DAKOOmnis,
dehydrated in alcohol, and cleared in xylene before
mounting with dibutylphthalate polystyrene xylene
(SigmaMillipore) and coverslipping.
Microscopy. DAB/HRP-stained slides were imaged
using a NanoZoomer microscope (2.0-HT, Hamamatsu),
with 1-4 manually set focus points per section. Images of
individual sections from L6 to S2 regions were taken
using NanoZoomer digital pathology viewing software
(NDP.view2, Hamamatsu) and analyzed using ImageJ
software. The images were not manipulated in any way.
Spinal cord pERK neuronal counts and analysis.
Neuronal counts were analyzed from previously saved
digital photomicrographs, with only neurons with intact
nuclei counted. The number of pERK-IR neurons in a
quadrant of the L6-S2 dorsal horn was obtained from
minimum 6 sections/animal viewed at 10 magnifica-
tion. The mean number of pERK-IR neurons (6SEM)
in the superficial dorsal horn (SDH; LI-II), the dorsal
gray commissure (DGC), and the sacral parasympa-
thetic nuclei (SPN) in sacral spinal segments were com-
pared between vehicle- and Mrgpr agonist mixture-
treated mice. These regions are known to have roles in
nociceptive signaling and autonomic reflexes (Todd,
2010) and are known to be activated by bladder afferent
output (Grundy et al., 2018a, 2019a).
Experimental design and statistical analyses
Data are presented as mean6 SEM or the percentage of
afferents or neurons. Within the specific figure legends,
N indicates the number of animals, while n indicates the
number of independent afferents or neurons. Sample
size was based on historical data and the use of power
calculations. Statistical significance was reported at lev-
els of p , 0.05 (*), p , 0.01 (**), p , 0.001 (***), and
Figure 1. The MRGPRA3 agonist chloroquine evokes mechanical hypersensitivity in a cohort of bladder affer-
ents. A, Original recordings from an ex vivo nerve recording preparation showing bladder afferent firing and intra-
vesical pressure. Recordings show exaggerated whole nerve bladder afferent responses to distension following
intravesical infusion with chloroquine (100 mM). B, The sum total of afferent firing (total area under the curve;
0-30 mmHg) for each individual experiment showing bladder instillation with chloroquine (100 mM) significantly
increased bladder afferent firing to distension (*p , 0.05, paired t test, N= 5 mice). Dots indicate whole nerve
responses from individual mice before and after the itch cocktail. C, The relationship between intrabladder
/
pressure and volume (compliance) during graded bladder disten-
sion (30 ml/min from 0 to 30 mmHg) is unaffected by intravesical
administration of chloroquine (100 mM, not significant, p . 0.05,
repeated-measures two-way ANOVA, N = 5). Di, Post hoc single-
unit analysis of the multiunit ex vivo bladder recordings shown in
A identified bladder afferents that were responsive to chloroquine
(showing a .20% increase in afferent firing) in the presence of
chloroquine (****p, 0.0001, two-way repeated-measures ANOVA,
n=24 afferents, N=5 mice). Significant differences were observed at
the following distension pressures: 14 mmHg (p=0.0127), 16 mmHg
(p, 0.0001), 18mmHg (p=0.0385), 22 mmHg (p= 0.0079), 24 mmHg
(p, 0.0001), 26 mmHg (p, 0.0001), 28 mmHg (p, 0.0001), and
30mmHg (p, 0.0001) (Sidak’s multiple comparisons tests, with
*p, 0.05, **p, 0.01, #p, 0.001 indicated on the graph). Dii,
Chloroquine-responsive bladder afferents showing enhanced firing
as determined by the total number of action potentials fired
(****p, 0.0001, Wilcoxon matched-pairs signed rank test,
n = 24 afferents, N=5 mice). E, Post hoc single-unit analysis also identi-
fied bladder afferents unaffected by chloroquine when analyzed (Ei)
across the entire distension range (not significant, p. 0.05, two-way
repeated-measures ANOVA, n=42 afferents, N=5 mice) or (Eii) as the
total number of action potentials fired (not significant, p. 0.05,
Wilcoxon matched-pairs signed rank test, n=42 afferents, N=5 mice).
F, Original recordings of chloroquine (100 mM) responding (top) and non-
responding (middle) bladder afferents during controlled bladder distension
from 0 to 30 mmHg (bottom). G, Overall, 36% of single units (24 of 66)
bladder afferents showed a .20% increase in afferent firing to chloro-
quine. Data are mean 6 SEM. CQ, Chloroquine; AUC, area under the
curve. Impulses per second: imp/s1.
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p , 0.0001 (****). In some cases, because of space li-
mitation, # is used to indicate significance of p ,
0.0001 for multiple comparisons. Data were tested for
Gaussian distribution using Prism 8 (GraphPad) to
determine whether they were normally distributed or
not and therefore the correct statistical tests to be
used. Data were then analyzed accordingly using
Prism 9.02 (GraphPad), via one- or two-way ANOVA
with Tukey’s or Sidak’s post hoc analyses dependent
on data distribution, or Student’s t tests, for parametric
data. Nonparametric data were analyzed using Kruskal–
Wallis test with Dunn’s multiple comparisons, Mann–
Whitney analysis, or Wilcoxon matched-pairs signed
rank test. The specific tests used for the analysis of each
dataset, the T, F, and p values, plus the number of N or n
values are indicated within Results or within the individ-
ual figure legends.
Results
Mrgpr agonists induce distension evoked
mechanical hypersensitivity of bladder
afferents
In order to determine whether pruritogenic
receptors have a functional role in bladder sen-
sory signaling, we performed ex vivo bladder
afferent recordings and determined their mecha-
nosensitivity to bladder distension before and
during bladder instillation with Mrgpr agonists.
Intravesical application of the MrgprA3 agonist,
chloroquine, evoked bladder afferent hypersen-
sitivity to bladder distension in whole nerve
recordings as determined by the total area under
the curve of the response (Fig. 1A,B; t(4) = 3.816,
p=0.0188, paired t test). Analysis of the pres-
sure/volume relationship in the bladder during
repetitive graded bladder distensions before and
during chloroquine revealed no effect on bladder
compliance (Fig. 1C; F(15,64) = 0.3544, p=0.9856,
repeated-measures two-way ANOVA). This
indicates that the mechanical hypersensitivity
induced by bladder infusion of chloroquine is
Figure 2. The MRGPRC11 agonist BAM8-22 evokes mechanical hypersensitivity in a cohort of bladder afferents.
A, Original ex vivo recordings showing exaggerated bladder afferent responses to distension following intravesical
infusion with BAM8-22 (20mM). B, Total bladder afferent firing was significantly increased following bladder instilla-
tion with BAM8-22 (20mM, *p, 0.05, paired t test, N= 5 mice). C, Bladder compliance during graded bladder dis-
tension is unaffected by intravesical administration of BAM8-22 (20 mM, not significant, p . 0.05, repeated-
/
measures two-way ANOVA, N= 5). D, Post hoc single-unit analysis
demonstrated a population of BAM8-22-responsive bladder afferents
showing enhanced firing as determined (Di) across the distension
range (***p, 0.001, two-way repeated-measures ANOVA, n= 7
afferents, N= 5 mice). Significant differences were observed at the fol-
lowing distension pressures: 8 mmHg (p= 0.0331), 18mmHg
(p= 0.0014), 22mmHg (p= 0.0248), 26mmHg (p= 0.0028),
28mmHg (p= 0.0004), and 30mmHg (p, 0.0001) (Sidak’s multiple
comparisons tests, with *p, 0.05, **p, 0.01, ***p, 0.001,
#p, 0.0001 indicated on the graph) or as (Dii) as the total number
of action potentials fired (**p, 0.01, paired t test, n= 7 afferents,
N= 5 mice). E, Post hoc single-unit analysis also identified bladder
afferents unaffected by BAM8-22 when analyzed (Ei) across the entire
distension range (not significant, p. 0.05, two-way repeated-meas-
ures ANOVA, n= 28 afferents, N= 5 mice) or as (Eii) the total number
of action potentials fired (not significant, p. 0.05, Wilcoxon
matched-pairs signed rank test, n= 28 afferents, N= 5 mice). F,
Original recordings of BAM8-22 responding and nonresponding bladder
afferents during bladder distension from 0 to 30mmHg. G, Overall,
20% (7 of 35) of bladder afferents showed a.20% increase in affer-
ent firing to BAM8-22. Data are mean 6 SEM. Impulses per second:
imp/s1.
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not secondary to changes in bladder muscle func-
tion, which can indirectly influence bladder afferent
responsiveness. To further investigate the afferent
response, we performed post hoc single-unit analy-
sis. This analysis revealed that distinct populations
of bladder afferents became hypersensitive follow-
ing chloroquine application (called responders)
when analyzed across all distension pressures (Fig.
1Di; F(15,368) = 4.163, p, 0.0001, repeated-measures
two-way ANOVA) or measuring the total afferent
response (Fig. 1Dii; p, 0.0001, baseline: mean
49.176 SEM 8.595 vs chloroquine; 81.546 12.15,
Wilcoxon matched-pairs). In contrast, other affer-
ents were unaffected by chloroquine application
(called nonresponders) when measured across all
distension pressures (Fig. 1Ei; F(15,656) = 0.4762,
p=0.9526, repeated-measures two-way ANOVA)
or as the total afferent response (Fig. 1Eii; p=
0.4365, baseline: 127.16 14.97 vs CQ: 129.26 14.69,
Wilcoxon matched-pairs). Of the afferents that were
affected by chloroquine, the predominant effects were
apparent throughout most distension pressures from
14 to 30 mmHg (for full details, see Fig. 1Di,F; Sidak’s
multiple comparisons test, p=0.0385 – p, 0.0001).
Overall, 36% of bladder afferents were responsive to
chloroquine application (Fig. 1G).
To follow-up on these findings, we also used the
MrgprC11 agonist BAM8-22 and found that it also sig-
nificantly enhanced bladder afferent responses to blad-
der distension (Fig. 2A,B; t(4) = 2.797, p=0.0490,
paired t test), without affecting muscle compliance
(Fig. 2C; F(15,48) = 0.1091, p. 0.9999, repeated-meas-
ures two-way ANOVA). Single-unit analysis of
bladder afferents revealed that BAM8-22 also sen-
sitized a subpopulation of bladder afferents (Fig.
2Di, F(15,96) = 2.921, p= 0.0008, repeated-measures
two-way ANOVA; Fig. 2Dii, t(6) = 5.596, p=
0.0014, paired t test). Responsive afferents were
particularly affected at distension pressures 18
mmHg (for full details, see Fig. 2Di,F; Sidak’s mul-
tiple comparisons test, p= 0.0331 – p, 0.0001). In
Figure 3. The MRGPRC11/A4 agonist NPFF evokes mechanical hypersensitivity in a cohort of bladder affer-
ents. Ai, Ex vivo recordings show an enhanced afferent response to distension following intravesical infusion
with NPFF (50 mM). B, Total bladder afferent firing was significantly increased following bladder instillation
with NPFF (50 mM, *p , 0.05, paired t test, N= 5 mice). C, Bladder compliance is unaffected by intravesical
/
administration of NPFF (5 mM, not significant, p . 0.05, repeated-meas-
ures two-way ANOVA, N= 5 for each group). D, Post hoc single-unit anal-
ysis showed a population of NPFF-responsive bladder afferents showing
enhanced firing (Di) across distension pressures (****p, 0.0001, two-
way repeated-measures ANOVA, n= 12 afferents, N= 5 mice). Significant
differences were observed at the following distension pressures: 14mmHg
(p= 0.028), 18mmHg (p= 0.017), 22 mmHg (p= 0.0014), 24mmHg
(p = 0.0002), 26mmHg (p, 0.0001), 28 mmHg (p, 0.0001), and
30mmHg (p= 0.0002) (Sidak’s multiple comparisons tests, with
*p, 0.05, **p, 0.01, ***p, 0.001, #p, 0.0001 indicated on the
graph) or, as in Dii, the total number of action potentials fired
(****p, 0.0001, paired t test, n= 12 afferents, N= 5 mice). E, A popu-
lation of bladder afferents were unresponsive to NPFF based on (Ei)
responses across the distension range (not significant, p. 0.05, two-way
repeated-measures ANOVA, n= 17 afferents, N= 5) or (Eii) the total
number of action potentials fired (not significant, p. 0.05, paired t test,
n= 17 afferents, N= 5 mice). F, Example traces of responding and non-
responding bladder afferents to NPFF (50 mM) during bladder distension.
G, Overall, 41% of single unit (12 of 29) bladder afferents showed a
.20% increase in afferent firing to NPFF. Data are mean 6 SEM.
Impulses per second: imp/s1.
3906 • J. Neurosci., April 28, 2021 • 41(17):3900–3916 Grundy, Caldwell et al. · MrgprA3 and MrgprC11 Causes Bladder Hypersensitivity
contrast, another population was unaffected by BAM8-22 Fig.
2Ei, F(15,864) = 0.4244, p= 0.9724, repeated-measures two-way
ANOVA; and Fig. 2Eii, p= 0.6832, baseline: 120.26 15.38 vs
BAM8-22: 116.66 15.09, Wilcoxon matched pairs). Responsive
afferents constituted 20% of the bladder afferents recorded (Fig.
2G).
We also found that the MrgprC11/MrgprA4 agonist NPFF
evoked significant bladder afferent hypersensitivity (Fig. 3A,B;
t(4) = 8.091, p=0.0013, paired t test) that was independent of
changes in muscle compliance (Fig. 3C; F(15,48) = 0.2828,
p=0.995, repeated-measures two-way ANOVA). NPFF affected
the responsiveness of 41% of bladder afferents recorded (Fig.
3Di, F(15,144) = 3.417, p, 0.001, repeated-measures two-way
ANOVA, Fig. 3Dii, t(11) = 7.526, p, 0.0001, paired t test). In
contrast, NPFF did not affect another population of bladder
afferents (Fig. 3Ei, F(15,576) = 0.1821, p= 0.9998, repeated-meas-
ures two-way ANOVA; Fig. 3Eii: t(16) = 1.194, p= 0.250, paired t
test; Fig. 3F,G). Neither chloroquine, BAM8-22, nor NPFF
recruited “silent” afferents to become subsequently mechanosen-
sitive. Overall, these findings show that chloroquine, BAM8-22,
and NPFF all evoke hypersensitivity to distension in subpopula-
tions of bladder afferents, suggesting the Mrgpr receptors they
activate are expressed on specific subpopulations of bladder-
innervating DRG neurons.
In order to confirm that these effects were mediated via
Mrgpr activation, we performed additional ex vivo bladder affer-
ent recordings with tissue from Mrgpr-clusterD/ mice (Fig.
4A). In our previous studies focusing on colonic sensitivity, we
have shown that a combined application of Mrgpr agonists, as an
itch cocktail, causes pronounced colonic mechanical hypersensi-
tivity, an effect that is absent in Mrgpr-clusterD/ mice (Castro
et al., 2019). In the current study, we found that ex vivo bladder
afferent responses to graded distension in Mrgpr-clusterD/
mice were identical when comparing between the application of
vehicle or the itch cocktail of coapplied chloroquine, BAM8-22,
and NPFF (Fig. 4Bi, F(15,48) = 0.606, p= 0.854, repeated-measures
two-way ANOVA, Fig. 4Bii: t(3) = 0.463, p= 0.675, paired t test).
Additionally, these studies also showed that bladder compliance
was unaltered in vehicle or itch cocktail treated bladders from
Mrgpr-clusterD/ mice (Fig. 4C, F(15,48) = 0.046, p. 0.999,
repeated-measures two-way ANOVA). These findings confirm
the role of Mrgprs in chloroquine, BAM8-22, and NPFF induced
bladder afferent mechanical hypersensitivity.
MrgprA3 and MrgprC11 are expressed in subpopulations of
bladder-innervating DRG neurons
To determine the mechanisms by which Mrgpr agonists induce
distension-evoked bladder afferent hypersensitivity, we deter-
mined Mrgpr expression in DRG, as well as in bladder tissue.
Lumbosacral DRGs contain the cell bodies of sensory neurons
innervating a number of different pelvic organs, including.30%
of which innervate the mouse bladder (Christianson et al., 2007;
Grundy et al., 2018d). Therefore, we performed retrograde trac-
ing from the bladder wall to isolate those that innervate the
Figure 4. Bladder afferent responses to an itch cocktail are absent in Mrgpr-clusterD/ mice. A, Original recordings of bladder afferent firing and intravesical pressure during consecutive
bladder distensions (0-30 mmHg) with saline followed by the itch cocktail containing the Mrgpr agonists chloroquine (100mM), BAM8-22 (20 mM), and NPFF (50 mM). Afferent responses were
stable during saline infusion and unchanged after administration of the Mrgpr agonists. Bi, Group data from ex vivo afferent recordings using Mrgpr-clusterD/ mice showing almost identical
responses to bladder instillation of vehicle (saline) or an itch cocktail (not significant, p . 0.05, two-way repeated-measures ANOVA, N= 4 mice). Bii, Total bladder afferent firing was
unchanged following bladder instillation of an itch cocktail (not significant, p. 0.05, paired t test, N= 4 mice). Dots indicate whole nerve responses from individual mice before and after the
itch cocktail. C, Bladder compliance during graded bladder distension (30ml/min, 0-30 mmHg) was unaffected by intravesical administration of the Mrgpr agonist itch cocktail in Mrgpr-
clusterD/ mice (not significant, p. 0.05, two-way repeated-measures ANOVA, N= 4). Data are mean6 SEM.
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Figure 5. Mrgpr receptors are expressed by bladder-innervating DRG neurons. A, Single-cell RT-PCR of retrogradely traced bladder-innervating DRG neurons reveals the percentage of neu-
rons expressing and coexpressing genes encoding Mrgprs and Trp channels (n= 77 single cells from N= 6 mice). mRNA for MrgprA3 and MrgprC11 was expressed in 14% and 38% of bladder-
innervating DRG neurons, respectively. In contrast, MrgprD was expressed in only 6% of bladder-innervating DRG neurons. Trpa1 and Trpv1 mRNA transcripts were detected in 15% and 84% of
bladder-innervating DRG neurons. B, Donut plot showing expression and coexpression of genes encoding MrgprC11, MrgprA3, MrgprD, Trpa1, and Trpv1 in 77 individual retrogradely traced
bladder-innervating DRG neurons. Each color represents an individual gene. Bold coloring represents expression. MrgprA3 is represented in the outer ring, with Trpv1 in the inner ring.
Individual neurons are arranged radially, such that coexpression of genes in a single neuron can be easily identified running from outside to inside. C, The majority of bladder-innervating DRG
neurons that express MrgprA3 coexpress MrgprC11 (90%) and Trpv1 (81%). In contrast, a minor proportion of MrgprA3-expressing bladder DRG neurons also coexpress MrgprD (18%) or Trpa1
(36%). D, MrgprC11 is commonly coexpressed with Trpv1 (89%), but less so with MrgprA3 (34%), MrgprD (7%), and Trpa1 (25%). E, Of the very few cells that express MrgprD (5 of 77 neurons),
40% (2 of 5 neurons) coexpress with MrgprA3, MrgprC11, Trpv1, or Trpa1. F, mRNA expression of MrgprA3, MrgprC11, MrgprD, Trpv1, and Trpa1 in whole LS (L5-S1) DRG. Expression of MrgprD
mRNA is significantly higher than MrgprC11, MrgprA3, Trpv1, and Trpa1. MrgprC11 and MrgprA3 are significantly less abundant than Trpv1 and Trpa1 (*p, 0.05, **p, 0.01, ***p, 0.001,
****p, 0.0001, Kruskal–Wallis test with Dunn’s multiple comparisons post hoc test, n= 15 pairs of DRG from N= 5 mice). G-I, mRNA expression of MrgprA3, MrgprC11, and MrgprD (and the
abundantly expressed Trpv4 as a comparator) in bladder (G) detrusor smooth muscle, (H) mucosa, and (I) primary urothelial cells. Expression of all Mrgprs was similar between the detrusor,
urothelial cells, and mucosa (tissue samples from N= 3-5 mice). Data are mean6 SEM.
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bladder. Single-cell RT-PCR from retro-
gradely traced bladder-innervating DRG neu-
rons revealed that, of the 77 individual
neurons studied, 14% expressed MrgprA3,
while 38% expressed MrgprC11 (Fig. 5A,B).
In comparison, mRNA transcripts for Trpv1
and Trpa1, key channels involved in bladder
afferent function (Daly et al., 2007; DeBerry
et al., 2014), were detected in 84% and 15% of
bladder-innervating DRG neurons, respec-
tively. Interestingly, another pruritogenic
Mrgpr, MrgprD, was only expressed in 6% of
bladder-innervating DRG neurons, so was
not investigated further with functional stud-
ies (Fig. 5A,B). Coexpression analysis revealed
that the majority of bladder-innervating neu-
rons that express MrgprA3 coexpress
MrgprC11 (90%) and Trpv1 (81%), with a
smaller proportion coexpressing Trpa1 (36%)
or MrgprD (18%) (Fig. 5B,C). Bladder-inner-
vating MrgprC11-expressing DRG neurons
commonly coexpressed with Trpv1 (89%),
but less so with MrgprA3 (34%), TrpA1
(25%), or MrgprD (7%) (Fig. 5B,D). Of the
few cells that expressed MrgprD, 40% coex-
pressed with MrgprA3, MrgprC11, TrpV1, or
TrpA1 (Fig. 5B,E). Overall, no bladder-inner-
vating DRG neuron expressed the full reper-
toire of receptors investigated. Interestingly,
the Mrgpr expression profile in bladder-
innervating DRG neurons contrasts starkly
with that observed in the whole LS DRG,
whereby MrgprD mRNA is expressed in the
highest abundance (for full details, see Fig.
5F, p, 0.001, Kruskal–Wallis test, p=0.0355 –
p, 0.0001, Dunn’s multiple comparisons tests).
In terms of bladder tissue, MrgprA3, MrgprC11,
and MrgprD were either poorly expressed or
were expressed below the detection limit in the
detrusor (Fig. 5G, F(1.001,3.002) = 68.43, p=0.0037,
repeated-measures one-way ANOVA, with
MrgprA3 vs Trpv4: p=0.0108, MrgprC11 vs
Trpv4: p=0.0115 and MrgprD vs Trpv4:
p=0.0113, Tukey’s multiple comparisons test),
the mucosa (Fig. 5H, F(1.000,3.000) = 53.86,
p=0.0052 repeated-measures one-way ANOVA,
with MrgprA3 vs Trpv4: p=0.0158, MrgprC11
vs Trpv4: p=0.0158 and MrgprD vs Trpv4:
p=0.0158, Tukey’s multiple comparisons test),
or primary urothelial cells (Fig. 5I, F(3,14) = 1109,
p, 0.001, one-way ANOVA, with MrgprA3
vs Trpv4: p, 0.0001, MrgprC11 vs Trpv4:
p, 0.0001 and MrgprD vs Trpv4: p, 0.0001,
Tukey’s multiple comparisons test), particularly
when compared with an abundantly expressed
target, such as Trpv4 (Everaerts et al., 2010a,b).
Mrgpr mRNA expression was ;1000-
100,000 lower than expression of Trpv4.
Overall, these findings indicate that the
pruritogenic receptors MrgprC11 and
MrgprA3 are expressed on sensory neu-
rons innervating the bladder, and their
expressions profile correlates well with
Figure 6. A cohort of bladder-innervating DRG neurons respond to MRGPR agonists. A-C, Calcium responses
elicited by (A) chloroquine (CQ; 1 mM), (B) BAM8-22 (2 mM), and (C) NPFF (5 mM) in isolated, cultured, retro-
gradely traced, bladder-innervating LS DRG neurons loaded with fura-2 AM. Capsaicin was added at the end of
each experiment to investigate the functional coexpression of TRPV1 with the MRGPRs. Each line indicates an
individual neuron. Colored lines indicate bladder DRG neurons responding to MRGPR agonists. Orange capsaicin
traces represent bladder neurons that responded to BAM8-22, chloroquine, or NPFF. D, Percentage of bladder-
innervating DRG neurons responding to chloroquine (8.1%: 6 of 74 neurons), BAM8-22 (22.9%: 17 of 74 neu-
rons), or NPFF (16.2%: 12 of 74 neurons). E, Donut plot showing functional responsiveness of individual neu-
rons to chloroquine, BAM8-22, and NPFF. Bold coloring represents a functional response to an Mrgpr agonist.
Chloroquine is represented in the outer ring, with NPFF in the inner ring. Individual neurons are arranged radi-
ally, such that functional responsiveness of a single neuron to the Mrgpr agonists can be easily identified run-
ning from outside to inside. F, G, Example traces showing that bladder-innervating DRG neurons can respond
to more than one MRGPR agonist. H, All bladder-innervating DRG neurons responding to chloroquine also
responded to BAM8-22 (100%: 6 of 6 neurons), with 66.6% of chloroquine-responding neurons also responding
to NPFF (4 of 6 neurons). I, 35.2% of BAM8-22 responding neurons also responded to chloroquine (6 of 17 neu-
rons), with 58.8% responding to NPFF (10 of 17 neurons). J, Of the NPFF responding neurons, 41.6% (5 of 12
neurons) also responded to chloroquine, with 83.3% (10 of 12 neurons) also responding to BAM8-22.
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our observations that subpopulations
of bladder afferents display mechani-
cal hypersensitivity following applica-
tion of the respective Mrgpr agonists.
The relatively low expression of
Mrgprs in bladder tissue correlates
well with our findings that Mrgpr ago-




In order to confirm the results of our
single-cell RT-PCR at a functional level,
and to investigate the roles of Mrgpr
agonists in activating bladder-innervat-
ing DRG neurons, we measured intracel-
lular calcium ([Ca21]i) using fura-2 AM
in response to application of chloro-
quine, BAM8-22, and NPFF. Overall,
calcium imaging of dissociated bladder-
innervating DRG neurons revealed that
individual application of chloroquine
(Fig. 6A), BAM8-22 (Fig. 6B), or
NPFF (Fig. 6C) resulted in activation of
subpopulations of bladder-innervating
DRG neurons. Overall, 8.1%, 22.9%, and
16.2% of bladder-innervating LS DRG
neurons were activated by chloroquine,
BAM8-22, and NPFF, respectively (Fig.
6D,E). In series application of multiple
Mrgpr agonists demonstrated func-
tional coexpression of MrgprA3 and
MrgprC11 in populations of bladder-
innervating DRG neurons (Fig. 6E–J),
supporting our single-cell RT-PCR data
suggesting colocalization of MrgprC11
and MrgprA3 in bladder-innervating
DRG neurons.
To further investigate the role of
Mrgprs in modulating bladder sensa-
tion, we used whole-cell patch-clamp
electrophysiology of retrogradely traced
bladder-innervating DRG neurons. In
these studies, we coapplied the Mrgpr
agonists chloroquine, BAM8-22, and
NPFF at the same time as an itch cock-
tail, as used in some of our bladder
afferent recording studies (Fig. 7A).
We found that this mixture caused significant hyperexcit-
ability in a subpopulation (44%) of bladder-innervating DRG
neurons, as indicated by a significant decrease in the rheo-
base, or amount of current required to fire an action poten-
tial (Fig. 7Ai: responders: t(6) = 4.583, p = 0.0038, paired t
test, Fig. 7Aii,Aiii). These changes in responder neurons
were also accompanied by a significant increase in the num-
ber of action potentials fired at 2 rheobase (Fig. 7Bi: res-
ponders: t(6) = 4.044, p = 0.0068, paired t test, Fig. 7Bii,Biii).
In comparison, the neuronal excitability of another population
of bladder-innervating DRG neurons was unaffected by the
Mrgpr agonist mixture (Fig. 7Ai: nonresponders: t(8) = 1.155,
p= 0.281, paired t test, Fig. 7Bi: nonresponders: each row has
the same difference).
Peripheral activation of mrgprs in the bladder results in
activation of dorsal horn neurons within the lumbosacral
spinal cord
Based on our findings that activation of MrgprA3 and
MrgprC11 sensitized the response of a proportion of bladder
afferents ex vivo, we hypothesized that in vivo intrabladder infu-
sion of Mrgpr agonists should correspondingly enhance bladder
signaling into the dorsal horn of the spinal cord. Infusion of sa-
line into the bladder resulted in pERK immunoreactivity (pERK-
IR) in neurons within the LS spinal cord dorsal horn because
of low-level bladder distension (Fig. 8A,B). In LS spinal seg-
ments, pERK-IR was seen in the SDH (Fig. 8Aii,B), the SPN (Fig.
Figure 7. MRGPR agonists induce neuronal hyperexcitability in a cohort of bladder-innervating DRG neurons. A, Whole-cell
patch-clamp recordings of retrogradely traced bladder-innervating LS DRG neurons. Ai, The Mrgpr agonist mixture, referred to
in the figure as an itch cocktail significantly decreases the amount of current required to elicit an action potential in a subset (7
of 16) of bladder-innervating DRG neurons (rheobase; **p , 0.01, paired t test, n= 16 neurons from N= 5 mice). Another
population of bladder-innervating DRG neurons (9 of 16) were unaffected by the itch cocktail (not significant, p. 0.05; paired
Student t test, n= 9 neurons from N= 5 mice). Aii, Original recording of membrane voltage from a single bladder-innervating
DRG neuron during current ramp protocols. Each line indicates a 10 pA increase in current. In this example, an 80 pA current
was required to elicit an action potential under control conditions (gray trace). Aiii, Perfusion with the itch cocktail consisting
of chloroquine (1 mM), NPFF (5 mM), and BAM8-22 (2 mM) for 2 min onto the same DRG neuron reduced the amount current
required to elicit an action potential (green trace), indicating increased neuronal excitability in this “responding” neuron. Bi,
Application of the itch cocktail significantly increases the number of action potentials fired at a current twice (2) the rheobase
in a subset (7 of 16; 44%) of bladder-innervating DRG neurons (*p , 0.05, Wilcoxon matched-pairs signed rank test, n= 7
neurons from N= 5 mice). Other bladder-innervating DRG neurons were unaffected by the itch cocktail (9 of 16; 56%, not sig-
nificant, p. 0.05, paired t test, n= 16 neurons from N= 5 mice). Bii, Original whole-cell current-clamp recordings from a sin-
gle bladder-innervating DRG neuron during current-clamp protocols. Each line indicates a 10 pA increase in current. In this
example, an 80 pA current was required to elicit an action potential under control conditions, with 160 pA representing 2
rheobase (gray trace). Biii, Following a 2 min perfusion with the itch cocktail, the same DRG neuron dramatically increased the
number of action potentials at 2 rheobase (green trace), indicating an increase in neuronal excitability. Bi, Data are mean
6 SEM. LS, Lumbosacral; AP’s, action potentials.
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Figure 8. In vivo intrabladder administration of an MRGPR agonist itch cocktail results in enhanced activation of dorsal horn neurons within the lumbosacral spinal cord. A, pERK-IR was
measured to determine signaling within the lumbosacral (LS; L6-S2) spinal cord in response to intrabladder administration of saline or an itch cocktail of MRGPR agonists (chloroquine: 10mM,
BAM8-22: 20mM, NPFF: 5 mM). Ai, pERK-IR was significantly increased in the LS dorsal horn of WT mice administered the itch cocktail compared with those administered saline (**p, 0.01,
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8Aiii,B), and the DGC (Fig. 8Aiv,B). Infusion of the itch cocktail
by coapplying chloroquine, BAM8-22, and NPFF into the blad-
der resulted in significantly greater total numbers of pERK-IR
neurons in the LS spinal cord relative to saline infusion (Fig. 8Ai;
p=0.0025, saline: 16.346 1.030 vs itch cocktail: 21.656 1.125,
Mann–Whitney test, Fig. 8B). Furthermore, significant increases
in pERK-IR neurons were observed across the SDH (Fig. 8Aii:
p=0.0003, saline: 3.3406 0.249 vs itch cocktail: 5.5266 0.411,
Mann–Whitney test, Fig. 8B), SPN (Fig. 8Aiii: p= 0.0255, saline:
1.4586 0.178 vs itch cocktail: 1.9446 0.140, Mann–Whitney
test, Fig. 8B), and the DGC (Fig. 8Aiv: p=0.0219, saline:
10.896 0.860 vs itch cocktail: 13.456 0.743, Mann–Whitney
test, Fig. 8B), indicating that Mrgpr-evoked bladder afferent
hypersensitivity is relayed into the spinal cord and enhances
sensory signaling. To confirm that the effects we observed with
Mrgpr agonists are mediated via Mrgpr activation, we per-
formed the same in vivo experiments with Mrgpr-clusterD/
mice. Comparing Mrgpr agonist and vehicle-treated Mrgpr-
clusterD/ mice, we found no differences in the total number
of pERK-IR neurons in the LS spinal cord (Fig. 8Ci: p= 0.105,
saline: 18.146 0.854 vs itch cocktail: 20.366 0.739, Mann–
Whitney test, Fig. 8D), the SDH (Fig. 8Cii: p= 0.5172, saline:
3.9826 0.251 vs itch cocktail: 3.9296 0.217, Mann–Whitney
test, Fig. 8D), and the SPN (Fig. 8Ciii: p= 0.584, saline:
1.8866 0.171 vs itch cocktail: 1.7776 0.131, Mann–Whitney
test, Fig. 8D), with a small but significant increase in the DGC
(Fig. 8Civ: p= 0.031, saline: 11.806 0.654 vs itch cocktail:
13.806 0.546, Mann–Whitney test, Fig. 8D).
Baseline bladder afferent responses and signaling within the
spinal cord to bladder distension are unaltered inMrgpr-
clusterD2/2mice
In order to determine whether Mrgprs contribute to bladder
afferent responses to distension at baseline, we compared
responses in WT andMrgpr-clusterD/ littermate mice. Ex vivo
bladder afferent firing to bladder distension with saline showed
that responses were indistinguishable between WT and Mrgpr-
clusterD/ mice (Fig. 9A, F(15,272) = 0.037, p. 0.999, two-way
repeated-measures ANOVA). Similarly, following saline bladder
distension in vivo, the numbers of pERK-IR neurons within the
LS spinal cord were not significantly different between WT and
Mrgpr-clusterD/ mice (Fig. 9B, t(100) = 1.353, p=0.179,
unpaired t test; Fig. 9C, t(100) = 1.801, p=0.074, unpaired t test;
Fig. 9D, t(69) = 1.724, p= 0.089, unpaired t test; Fig. 9E, t(100) =
0.850, p= 0.396, unpaired t test). Overall, these findings suggest
that Mrgprs are not responsible for bladder afferent mechano-
sensitivity per se, but rather have a prominent role in sensitizing
bladder afferent responsiveness to distension following activation
by pruritogens.
Discussion
The ability of the somatosensory nervous system to easily differ-
entiate stimuli, such as pruritogens or algogens, is essential as it
evokes a tailored response, such as scratching or withdrawal of a
limb. As a consequence, there is significant functional and ana-
tomic diversity of somatosensory afferent nerves. In contrast,
sensory discrimination in the bladder is more limited in scope,
ranging from fullness to urge and finally pain (de Groat et al.,
2015). Therefore, the differentiation of distinct sensory stimuli
(inflammation, infection, irritation) is less important if the
overarching physiological response remains the same: increased
voiding to rapidly remove irritants from the bladder. As such,
mechanosensitive afferents innervating the bladder are less
diverse than cutaneous afferents. The majority of bladder affer-
ent neurons are embedded within the detrusor smooth muscle
(de Groat et al., 2015; Spencer et al., 2018; Grundy et al., 2019a,
b), and are broadly tuned to allow the detection of a variety of
mechanical and chemical stimuli (Rong et al., 2002;
Zagorodnyuk et al., 2006, 2007; de Groat and Yoshimura, 2009a;
Grundy et al., 2019b). Therefore, the excitability of these affer-
ents is key in providing appropriate sensory information in
response to stimuli, including bladder filling and emptying.
Understanding the mechanisms responsible for regulating blad-
der afferent mechanosensitivity is therefore crucial to the devel-
opment of novel treatments for the chronic sensory symptoms
associated with bladder hypersensitivity and dysfunction, includ-
ing urinary urgency, frequency, and pelvic pain. In this study, we
discovered a novel role in bladder sensory afferent pathways for
irritant sensing mechanisms mediated via MrgprC11 and
MrgprA3.
Consistent with previous reports that Mrgpr agonists are able
to excite isolated peripheral sensory neurons (Q. Liu et al., 2009;
Castro et al., 2019; Tseng et al., 2019), we showed, using patch-
clamp recordings, that chloroquine, BAM8-22, and NPFF acti-
vated and induced neuronal hyperexcitability in subpopulations
(44%) of bladder-innervating DRG neurons. In calcium imaging
experiments, we observed some functional overlap between
responses to chloroquine and BAM8-22, which has been previ-
ously described in afferents innervating the skin (Q. Liu et al.,
2009) and colon (Castro et al., 2019). Using single-cell RT-PCR
of bladder DRG neurons, we revealed expression and coexpres-
sion of Mrgprs in bladder-innervating neurons. The majority of
neurons expressing MrgprC11 also contained MrgprA3, consist-
ent with previous reports of colocalization in other sensory path-
ways (Dong et al., 2001; Zylka et al., 2003; Han et al., 2013;
Castro et al., 2019).
High colocalization of MrgprA3 and MrgprC11 was also
observed with Trpv1 in bladder DRG neurons, either on an
mRNA level with single-cell RT-PCR, or functionally with blad-
der neurons exhibiting calcium transients in response to chloro-
quine, BAM8-22, NPFF, and the TRPV1 agonist capsaicin. This
is expected as the majority of bladder-innervating DRG neurons
express Trpv1 (La et al., 2011; Dang et al., 2013; Forrest et al.,
2013), while TRPV1 is a key integrator of histamine and P2X3-
dependent bladder afferent activation (Grundy et al., 2018a,
/
Mann–Whitney test, n= 47-76 sections from spinal regions L6-S2; N= 5 mice). Aii-Aiv, WT
mice administered the intrabladder itch cocktail displayed significantly increased pERK-IR in
specific regions of the dorsal horn, including the (Aii) SDH, (Aiii) SPN, and (Aiv) DGC (*p,
0.05, ***p, 0.001, Mann–Whitney tests). Data are presented as numbers of pERK-IR neu-
rons/section of the LS spinal cord, with a minimum of 6 sections/mouse. B, Representative
pERK-labeled LS spinal cord images at each spinal level (L6-S2) from mice that had bladders
infused with either saline or an MRGPR agonist itch cocktail. Yellow arrows indicate pERK-IR
neurons. Scale bar, 250mm. Ci, In contrast to WT mice, pERK-IR was not significantly differ-
ent across the whole LS dorsal horn of Mrgpr-clusterD/ mice administered either intra-
bladder saline or the MRGPR agonist itch cocktail (not significant, p. 0.05, Mann–Whitney
test, n= 55-91 sections from N= 5 mice). Cii, Ciii, pERK-IR was not significantly altered in
the (Cii) SDH, (Ciii) nor the SPN (not significant, p . 0.05, Mann–Whitney tests, N= 5
mice). Civ, Following the itch cocktail infusion, there was a small but significant increase in
pERK-IR in the DGC that remained in Mrgpr-clusterD/ mice (*p , 0.05; Mann–Whitney
tests, N= 5 mice). Data are presented as numbers of pERK-IR neurons/section of the LS spi-
nal cord, with a minimum of 6 sections/mouse. D, Representative pERK-labeled LS spinal
cord images at each spinal level (L6-S1) from Mrgpr-clusterD/ mice that had bladders
infused with either saline or the MRGPR agonist itch cocktail. Yellow arrows indicate pERK-IR
neurons. Scale bars, 250mm. Data are mean6 SEM.
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2020). These findings are consistent with the literature suggest-
ing that MrgprA3-positive neurons are in a subpopulation of
Trpv1-positive neurons (Han et al., 2013; Usoskin et al., 2015;
Meixiong and Dong, 2017). However, these mechanisms in the
bladder, where only 15% of bladder neurons express Trpa1,
appear to contrast with those in the colon and skin. For example,
Mrgpr agonist-induced mechanical hypersensitivity to colorectal
distension is not evoked in Trpa1/ mice (Castro et al., 2019).
In the skin, TRPA1 has been identified as the downstream tar-
get of both MrgprA3 and MrgprC11, whereby Trpa1/ mice
display little to no scratching in response to chloroquine or
BAM8-22, with functional coupling of MrgprA3 or MrgprC11
to TRPA1 occurring via Gb g and PLC signaling, respectively
(Wilson et al., 2011).
Differences are also apparent between bladder and cutaneous
neurons when interrogating the role of MrgprD. Within cutane-
ous populations, two distinct pruritogenic subpopulations of
DRG neurons have been identified: those expressing MrgprA3,
MrgprC11, and histamine receptor 1 (H1R), and those expressing
MrgprD (Q. Liu et al., 2009, 2012; Usoskin et al., 2015). MrgprD,
initially postulated to play an important nociceptive role, is now
known to mediate itch induced by the amino acid b -alanine
(Shinohara et al., 2004; Q. Liu et al., 2012). Despite high MrgprD
expression in whole LS DRG, only 6% of bladder-innervating
DRG neurons expressed MrgprD, which showed equal coexpres-
sion (40%) with MrgprC11 and MrgprA3. This suggests a far
more prominent role for MrgprC11 and MrgprA3 than MrgprD
in bladder sensory function.
In keeping with this reasoning, we show that chloroquine,
BAM8-22, and NPFF enhanced the mechanosensitivity of subpo-
pulations (20%-41%) of WT pelvic bladder afferents to bladder
distension, which did not occur in experiments with Mrgpr-
clusterD/ mice. The proportion of WT afferents responding
to these Mrgpr agonists correlated reasonably well with the pro-
portion of isolated lumbosacral bladder neurons responding to
MrgprA3 (8%) and MrgprC11 (23%) agonists in calcium imag-
ing experiments and the percentage of lumbosacral bladder
DRG neurons expressing mrgprA3 (14%) and mrgprC11 (38%).
Differences between the exact proportions may be because of
culture times, 4 h was for single-cell RT-PCR and 18-48 h was
for calcium imaging. A recent study identified that only 4% of
bladder neurons express mrgpra3; however, they were isolated
from both thoracolumbar and lumbosacral DRG, and no func-
tional responses were investigated (Meerschaert et al., 2020).
Differences between these studies are likely because of the location
of the neurons and the specific culture conditions, including using
different enzymes and media supplementation.
Mrgpr mRNA expression in bladder tissue was extremely low
or below the detection limit, explaining why intrabladder instilla-
tion of Mrgpr agonists did not affect bladder compliance. These
findings are in keeping with a number of studies showing that
these Mrgprs are expressed almost exclusively in sensory struc-
tures, including cell bodies of sensory neurons located in the
DRG, trigeminal, and jugular ganglia (Dong et al., 2001; Han et
al., 2013, 2018; Meixiong and Dong, 2017; Castro et al., 2019).
We found that Mrgpr agonists evoked bladder afferent me-
chanical hypersensitivity across a broad range of distension
Figure 9. Mrgpr-clusterD/ mice do not display altered baseline responses to bladder
distension. A, Group data from ex vivo recordings from WT mice and age-matched Mrgpr-
clusterD/ mice. There was no significant difference in the mechanosensitivity of bladder
afferents in response to graded bladder distension (0-30 mmHg) between WT and Mrgpr-
clusterD/ mice (not significant, p . 0.05, two-way ANOVA, N= 4-15 mice). B-E,
Compared with WT mice, Mrgpr-clusterD/ mice do not display altered neuronal activation
within the dorsal horn of LS spinal cord following intrabladder vehicle administration. pERK-
IR was measured to determine signaling in the lumbosacral (LS; L6-S2) spinal cord in
response to saline instillation in WT and age-matched Mrgpr-clusterD/ mice. There was
no difference in (B) the total number of pERK-IR neurons identified within the LS dorsal horn
in response to saline infusion into the bladder between WT and Mrgpr-clusterD/ mice. In
terms of specific regions of the LS dorsal horn, there were significant differences between
/
WT and Mrgpr-clusterD/ mice in the number of pERK-IR neurons following intrabladder
administration within the (C) SDH, (D) SPN, and (E) DGC regions of the dorsal horn (not sig-
nificant, p. 0.05, unpaired t tests, N= 5 mice/group). Data are mean6 SEM.
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pressures. Unlike other irritant and inflammatory stimuli, such
as histamine or inflammatory cytokines, Mrgpr agonist incuba-
tion did not recruit silent afferents to become mechanosensitive
(Brierley et al., 2020; Grundy et al., 2020). This is an important
distinction as silent afferents represent a discrete functional
subclass of bladder afferents, that after becoming sensitized ac-
quire an ability to respond to “high-threshold” or “nociceptive”
mechanosensory stimuli (Prato et al., 2017; Zhang et al., 2019;
Brierley et al., 2020). These findings are consistent with
MrgprA3- and MrgprC11-positive neurons that have previ-
ously been reported as being responsive to mechanical stimuli,
including probing of cutaneous receptive fields (Han et al.,
2013). Furthermore, a recent study investigating the role of
Mrgprs in colonic afferent mechanosensitivity found that
MrgprA3- and MrgprC11-positive fibers are also sensitive to
mechanical stimulation (Castro et al., 2019). Mrgpr-positive cu-
taneous nerve endings have been reported to exclusively inner-
vate the epidermis (Han et al., 2013); however, this does not
appear to be the case in the bladder. While some mechanosensi-
tive afferents innervate the bladder mucosa, an equivalent to
the epidermis, the majority of mechanosensitive bladder affer-
ents are found innervating the bladder detrusor (Zagorodnyuk
et al., 2007; Spencer et al., 2018), and we observed significant
hypersensitivity of these distension sensitive afferents to Mrgpr
agonists.
The homogeneity of bladder sensory pathways is further
reflected in their activation of spinal cord circuits in response to
bladder distension, which, unlike the distinct organization of pri-
mary afferent circuits that occurs in the spinal cord for process-
ing specific somatosensory stimuli (Todd, 2010), appears graded
only to the level of peripheral stimuli (Grundy et al., 2018a). As
such, an increase in the intensity of the peripheral afferent signal
corresponds to increased activation of second-order neurons
that project within multiple visceral sensory pathways to regulate
networks responsible for both micturition and sensation, rather
than any obvious sensation-specific activation. Accordingly, we
found that Mrgpr activation of peripheral afferents in the bladder
in vivo resulted in significant increases in the number of pERK-
IR neurons in all regions of the lumbosacral dorsal horn that
receive input from mechanosensitive afferents (Grundy et al.,
2019b). This included increased numbers of neurons within the
SDH, DGC, and SPN. As such, we would expect that the physio-
logical consequence of an Mrgpr-induced increase in afferent fir-
ing would be similar to other stimuli that evoke an increase in
primary afferent excitability from the bladder: urinary urgency
and urinary frequency.
Interestingly, we observed no difference in bladder afferent
mechanosensitivity nor activation of central pathways in the spi-
nal cord to distension with saline between Mrgpr-clusterD/
mice and WT mice. Similar observations have been made before
in other sensory pathways, where Mrgpr-clusterD/ mice do
not show deficits in cutaneous mechanosensation (Q. Liu et al.,
2009). Furthermore, in the colon, Mrgpr-clusterD/ mice had
similar visceromotor responses to WT mice (Castro et al., 2019).
Overall, these data suggest that endogenous activators of
MrgprC11 and MrgprA3 are not tonically released from the
bladder to set the baseline tone of bladder afferent mechanosen-
sitivity; however, it has yet to be established whether compensa-
tory changes occur in Mrgpr-clusterD/ mice to maintain
normal function.
While no known endogenous MrgprA3 agonists have been
documented, endogenous MrgprC11 agonists include BAM8-22,
proenkephalin A, SLIGRL, NPFF, and cathepsin S, which may be
found in a variety of different cell types, including fibroblasts, ke-
ratinocytes, mast cells, macrophages, and microglia (M. G. Lee et
al., 2008; Q. Liu et al., 2009; Slominski et al., 2011; T. Liu and Ji,
2013; LaMotte et al., 2014; Reddy et al., 2015; Montague-
Cardoso and Malcangio, 2020). Whether or not Mrgprs or their
endogenous agonists are upregulated in conditions of bladder
pathophysiology is the subject of future research.
In conclusion, we have shown that MrgprC11 and MrgprA3
are present and functional on mechanosensitive bladder affer-
ents, and their activation induces mechanical hypersensitivity
and increased activation of sensory circuits within the spinal
cord. Enhanced sensation via an increase in mechanosensitivity
may be a fundamental protective mechanism and relate more
specifically to bladder disorders associated with urgency and fre-
quency in the absence of pain, such as overactive bladder.
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